Bayer announced an agreement to fully acquire Perfuse Therapeutics Inc., a biopharmaceutical company developing treatments for ischemia-induced ocular diseases. The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions